Louis Manzo, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 10,000 shares at $3.10 ($31K) on 2017-05-09, disclosed to the SEC on 2017-05-11.
Open-market purchase of $31k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |